Wichita Urology Group, P.A.

Appointments: 316.636.6100
Billing: 316.636.6165

Did you know… - da Vinci® Prostatectomy is the #1 choice for treatment of localized prostate cancer in the United States, and is rapidly being chosen by more men, as well as their doctors, worldwide. da Vinci Prostatectomy is a minimally invasive, robotic-assisted surgical procedure that removes the cancerous prostate gland and related structures. The board certified physicians at Wichita Urology Group in Wichita, KS are specialty trained in da Vinci procedures.


learn more

What's New

  • Click below to listen to Dr. Gregory Byrd talking to KQAM about prostate cancer awareness

  • Watch Dr. Jeffery Davis talk about Prostate Cancer Screening on
    Channel 12
  • The great prostate cancer "hoax": A call to arms
    (05/05, Henrey Rosevear MD):
    "I recently read a very disturbing book that I wanted to share with everyone, as it presented a point of view that I, as a urologist, do not commonly encounter. “The Great Prostate Hoax: How Big Medicine Hijacked the PSA Test and Caused a Public Health Disaster,” by Richard Ablin and Ronald Piana (Palgrave Macmillan) was only recently published, but a quick Google search shows just how much publicity it is receiving"
    [View Artticle]
  • Dr. Jeffery Davis wrote for MD News:
    "Committed to Advanced Urologic Care"
    [View Article]
  • AUA Position Statement on Testosterone Therapy
    The American Urological Association (AUA) has followed closely the recent media attention regarding reports that testosterone therapy increases cardiovascular events in men as well as the FDA's stated intent to review cardiovascular risk with this treatment in men with hypogonadism ....
    [Read More]
  • Testosterone Therapy and Cardiovascular Risks
    A position statement by the Sexual Medicine Society of North America, Inc (SMSNA)
    [View Article]
  • A featured research from UCLA on Science Daily shines light on the benefit of robotic-assisted prostate surgery in controlling prostate cancer
    [View Article]
  • Dr. Gregory Byrd wrote for MD News: " Treatment of Advanced Prostate Cancer"
    [View Article]
  • Position Statement on Mesh Midurethral Slings for Stress Urinary Incontinence, by American Urogynecologic Society (AUGS) and the Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (SUFU)
    [View Article]
  • Wichita Urology Announces New Radiation Oncology Center At Wilson Estate (WICHITA, KS) , Laham Development has announced plans for a new radiation oncology center at Wilson Estates. The Wichita Urology Group will open Advanced Cancer Therapies, a state of the art cancer facility, in the spring of 2014.
    [Read More]
  • Prostate Cancer Infolink (8/29, Chuck) blogged, "Payers tell PBRT centers that they need better data to justify high prices"
    [ View Blog ]
  • Dr. George Zakharia Wrote for Doc Talk section in Wichita Eagle: "Why Men Need Regular Screening For Prostate Trouble"
    [ View Article ]
  • Wichita Urology physicians  support the Choosing Wisely® campaign
    [Read More]
  • NPR (10/29/2012, Stein) "Pricey Prostate Cancer Therapy Raises Questions About Safety, Cost"
    [ See Blog ]
  • Dr. Timothy A. Richardson Wrote for MD News: "Robotic Surgery" 
    [ View Article ]
  • Dr. Fadi N. Joudi Wrote for MD News: " Recommendation Against PSA Screening for Prostate Cancer Puts Men’s Lives at Risk"  [ View Article ]
  • WebMD (4/18, DeNoon) reports, "The study analyzed data from 6,666 men treated with IMRT, 6,310 men treated with 3D conformational therapy, and 684 men treated with proton beam therapy."
  • HealthDay (4/18, Dotinga) reports that "proton therapy costs about $50,000 per patient, roughly twice as much as IMRT, study co-author" Dr. Ronald Chen "said."
  • MedPage Today (4/18, Fiore) reports that the researchers found that "men who had IMRT were less likely to need additional cancer therapy (RR 0.81, 95% CI 0.73 to 0.89)." These patients "were also less likely to have gastrointestinal comorbidities (RR 0.91, 95% CI 0.86 to 0.96) and hip fractures (RR 0.78, 95% CI 0.65 to 0.93) than those who had conformal radiation therapy, although they were more likely to have erectile dysfunction (RR 1.12, 95% CI 1.03 to 1.20)." Men "who had proton therapy, on the other hand, didn't gain any advantages over IMRT patients in terms of mortality or additional cancer therapy -- but they did have a higher risk of gastrointestinal morbidity, the researchers found.
  • "What patients should know about Prostate Cancer screening tests Prostate cancer is the most common non-skin cancer in men in the United States, and the second leading cause of cancer death in men. Early detection may save lives. Recent reports about prostate specific antigen (PSA) testing present conflicting information about the value of this critical prostate-cancer screening test. The benefits of regular screening and early detection should not be discounted in the overall population.
  • Data show clinical advantages to robotic surgery - With a 3-D view and greater dexterity, the da Vinci surgical robot offers many advantages.
  • ABC News Profile on da Vinci Surgery New research suggest doctors will perform better with robotic assistance.
    [ View Now ]

®

Health Library

View our comprehensive online library of health care topics. [ click here ]

Patient Tutorials

View our interactive patient education tutorials on prostatectomy, cystectomy and more. [ view now ]

Prostate Cancer

More than 210,000 men will be diagnosed this year and more than 30,000 will die from prostate cancer. Don't be that statistic. [ click here ]

health library

Two convenient locations ready to serve you. [ click here ]